# A Study to Evaluate the Efficacy and Safety of a Leave-in Spray in Subjects With Head Lice Infestation

> **NCT05565820** · PHASE4 · COMPLETED · sponsor: **Alliance Pharmaceuticals** · enrollment: 58 (actual)

## Conditions studied

- Pediculosis Capitis
- Lice Infestations
- Head Lice

## Interventions

- **OTHER:** Vamousse Spray 'n' Go
- **DRUG:** Nix Creme Rinse Lice Treatment

## Key facts

- **NCT ID:** NCT05565820
- **Lead sponsor:** Alliance Pharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-12-15
- **Primary completion:** 2023-03-12
- **Final completion:** 2023-03-12
- **Target enrollment:** 58 (ACTUAL)
- **Last updated:** 2025-02-24

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05565820

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05565820, "A Study to Evaluate the Efficacy and Safety of a Leave-in Spray in Subjects With Head Lice Infestation". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT05565820. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*